Watchlist Price Alert

Matinas BioPharma Inc. (MTNB)

AMEX: MTNB · Real-Time Price · USD

0.94

0.10 (11.90%)

At close: Jun 16, 2025, 3:59 PM

0.89

-5.36%

Pre-market: Jun 17, 2025, 09:21 AM EDT

Matinas BioPharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	1.1M	3.19M	33.33K	158.33K	90K	119.75K	149.69K	n/a
Cost of Revenue	972K	14.49M	16.68M	781.49K	14.36M	11.23M	6.79M	9.01M	52.64K
Gross Profit	n/a	-13.39M	-13.49M	-748.16K	-14.2M	-11.14M	-6.67M	-8.86M	-52.64K
Operating Income	-24.59M	-23.77M	-24.59M	-24.73M	-24.21M	-18.92M	-14.65M	-16.5M	-8.26M
Interest Income	n/a	n/a	n/a	3K	7K	11.7K	n/a	n/a	n/a
Pretax Income	-24.25M	-22.94M	-21M	-23.28M	-22.45M	-17.37M	-14.59M	-15.84M	-7.6M
Net Income	-24.25M	-22.94M	-13.02M	-21.17M	-20.6M	-15.59M	-14.08M	-15.49M	-7.6M
Selling & General & Admin	8.73M	10.37M	11.1M	10.18M	10.01M	7.78M	7.98M	7.64M	4.31M
Research & Development	11.43M	14.49M	16.68M	14.58M	14.36M	11.23M	6.79M	9.01M	3.95M
Other Expenses	n/a	n/a	-16.68M	122.87K	686.42K	541K	56.55K	22.03K	-16.5K
Operating Expenses	20.16M	24.86M	11.1M	24.77M	24.36M	19.01M	14.77M	16.65M	8.26M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	24.59M	24.86M	27.78M	24.77M	24.36M	19.01M	14.77M	16.65M	8.26M
Income Tax Expense	-80K	n/a	-7.98M	-2.11M	-1.85M	-1.79M	-506.92K	-356.96K	-674.9K
Shares Outstanding (Basic)	4.87M	4.35M	4.34M	4.2M	3.94M	2.9M	1.96M	1.81M	1.15M
Shares Outstanding (Diluted)	4.87M	4.35M	4.34M	4.2M	3.94M	2.9M	1.96M	1.81M	1.15M
EPS (Basic)	-4.98	-5.28	-3	-5.04	-5.23	-5.37	-7.18	-8.56	-6.59
EPS (Diluted)	-4.98	-5.28	-3	-5.04	-5.23	-5.37	-7.18	-8.56	-6.59
EBITDA	-23.36M	-22.82M	-24.23M	-24.45M	-23.92M	-18.59M	-14.43M	-16.4M	-8.2M
EBIT	-24.33M	-23.77M	-24.59M	-24.73M	-24.21M	-18.92M	-14.65M	-16.5M	-8.26M
Depreciation & Amortization	972K	941K	898K	781.49K	774.59K	780.82K	218.31K	100.61K	52.64K